ACE Biolabs has been at the forefront in the fight against COVID-19 in Taiwan. Starting from gathering COVID-19 (SARS-CoV-2) virus antibody and antigens as raw materials of diagnostic detection solutions. In order to provide the most suitable raw materials, we repeated screen all the raw materials and starting to invest in development of COVID-19 detection.
ACE Biolabs’ COVID-19 Total Solutions for Detection and Surveillance including
Learn More about ACE Biolabs' COVID-19 Total Solutions for Detection and Surveillance
The detection kit can detect as well as identify RBD antigen of COVID-19 (SARS-CoV-2) virus in aquatic products, e.g. fish and shrimp, livestock, e.g. pigs, cattle and sheep, and the environment by using colloidal gold immunochromatography. The reagent pad contains anti-COVID-19 (SARS-CoV-2) virus RBD antibody conjugated with colloidal gold particles and the secondary antibody against anti-COVID-19 (SARS-CoV-2) virus RBD antibody are immobilized in a line across the reaction membrane as a test line (T line). The COVID-19 (SARS-CoV-2) virus RBD is first captured by colloidal gold conjugated anti-RBD antibody and the antigen-antibody-conjugate complex is formed during testing process. The Ag-Ab complex then is detected by the secondary antibody coated on the T line while migrates across the reaction membrane and a visible pink signal band is formed. If there is no COVID-19 (SARS-CoV-2) virus RBD antigen contained in the sample, no pink band will appear at the T line. The quality control line (C line) on the reaction membrane is an indicator of product effectiveness. No matter whether the signal at T line appears or not, a pink line should always appear at C line. If no pink signal is shown at C line, it indicated that the test result is invalid and additional testing is required.
This testing kit uses RT-LAMP (Reverse Transcription-Loop-mediated Isothermal Amplification) technology combining visualizing method to perform amplification detection of the RBD region in COVID-19 (SARS-CoV-2) virus RNA, which can detect and identify the RBD antigen of COVID-19 (SARS-CoV-2) virus in aquatic products, e.g. fish and shrimp, livestock, e.g. pigs, cattle and sheep, and the environment.
This product is a multiplex fluorescent probe-based Taqman® RT-qPCR assay system. This product provides triplex-detections in a single tube, including two independent genes of COVID-19 (SARS-CoV-2) virus and an internal control which targets the human RNAse P (RNP) gene to assess specimen quality.
This kit contains essential reagents for the development of COVID-19 IgG/IgM Lateral Flow (Rapid Test) assay to help with the qualitative detection of IgG and IgM antibodies specific to SARS-CoV-2 in human biological fluids.
researches on COVID-19 have reported highly relation between COVID-19 virus infection and cytokine storm.
ACE Biolabs is actively in the process of developing COVID-19 IgG/IgM Dual Detection Kits (Colloidal Gold-Based) and providing raw materials of diagnostic detection kit, such as SARS-CoV-2 antigens (Nucleocapsid protein and Spike protein), Anti-SARS-CoV-2 antibodies (anti-NP and anti-S), Pseudovirus and RT-qPCR reagents.
ACE Biolabs used the lentiviral packaging system to package the SARS-CoV-2 (2019-nCoV, COVID-19 virus) S protein as a surface capsid glycoprotein and containing GFP and Luciferase dual reporter genes as a pseudovirus model. The virus can infect cell lines overexpressing the ACE2 gene. Researchers can determine the infection efficiency by observing GFP through a microscope and detecting the value of Luciferase.